Brazilian oral research最新文献

Poor oral health can negatively impact overall health and quality of life. Understanding how oral health predicts weakness in older adults is critical, since weakness increases the risk of health outcomes. However, the predictive role of oral health indicators in weakness among older adults remains unclear. This study assessed the ability of oral health indicators to predict weakness using data from Brazil's EpiFloripa Aging cohort study. Predictive validity was evaluated in a sample of older adults participating in the cohort's second (n = 440) and third (n = 347) waves. Self-reported sociodemographic, general health, and oral health variables were analyzed, with weakness diagnosed using cut-off points for handgrip strength. Predictive models incorporating sociodemographic, general health, and oral health variables were tested. Receiver operating characteristic curves, sensitivity and specificity, and positive and negative predictive values were calculated. Approximately 45.9% of the participants had two to three compromised oral health indicators during the second wave, and the five-year incidence of weakness was 31.9%. Oral health indicators and the oral frailty score did not enhance the prediction of weakness compared to models based solely on demographic, socioeconomic, and general health variables. However, models including oral health indicators demonstrated predictive accuracy comparable to those with demographic, socioeconomic, and general health variables. Sensitivity values were low (3.70-6.48%), while specificity values were high (>99%), with accuracy ranging from 0.64 to 0.71. These findings suggest that oral health indicators offer comparable predictive validity for weakness as sociodemographic and general health models, potentially serving as useful tools for health teams in screening older adults for weakness.

A cross-sectional study was carried out among patients with ulcerative colitis (UC) and Crohn's disease (CD) in order to determine the frequency of oral mucosal lesions or conditions (OL), as well as to analyze its relationship with some clinical and laboratory parameters. Epidemiologic, clinical, and laboratory data were considered. Statistics included univariate and multivariate analyses. Ninety patients [46 (51.1%) males] were included [median age: 43 years (range 18-79 years)]. UC was diagnosed in 65 (72.2%) patients; CD in 25 (27.8%) patients; and inactive CD was detected in 78 (86.6%) patients. All patients (100%) had OL; fissured tongue was the most frequent finding [68 (75.6%)]. Furred tongue was more common in UC than in CD patients [45 (69.2%) vs. 11(44.0%); p = 0.03]; lower levels of hemoglobin were more often detected in mucosal pallor [(median (Md) =12.1 vs. 14.4g/dL); p = 0.02] than in other OLs. Higher frequency of melanosis was observed when oral rinses were used [37 (71.2%) vs. 15 (28.8%)]; p = 0.03], compared to those who did not use them. A higher risk of varix [OR: = 37.6 (95%CI: 4.7-298.9), p < 0.001], leukoedema [OR: 5.8 (95%CI: 1.4-24.2); p = 0.004], candidosis [OR: 3.9 (95%CI: 1.4-10.6); p = 0.05], fissured tongue [OR: 3.8 (95%CI: 1.2-11.5); p = 0.01], and all infectious processes analyzed collectively [OR: 3.6 (95%CI: 1.3-9.8); p = 0.03], was found in patients older than 45 years than in younger ones. Also, patients with fissured tongue presented a higher risk of having candidosis than those without this condition [OR: 6.1 (95%CI: 2.1-17.5); p = 0.007]. OLs were highly frequently observed in UC and CD patients. Age (> 45 years), low levels of hemoglobin, use of mouthwashes, among other variables, were predictive factors of OL in these patients; thus, their assessment and detection in inflammatory bowel disease should be emphasized.

The etiological intersection between orofacial clefts and oral cancer may involve environmental factors modulating gene expression in shared biological pathways. This study aimed to investigate the association between orofacial clefts and oral potentially malignant disorders or oral squamous cell carcinoma, focusing on genetic variants and environmental risk factors. A case-control design was employed, comprising 48 histologically confirmed cases of oral potentially malignant disorders or oral squamous cell carcinoma and 96 age- and sex-matched controls. Information on family history of orofacial cleft, and biological and environmental risk factors, was collected through interviews. Genomic DNA was extracted from saliva samples and genotyped for rs1533767 (WNT11), rs9879992 (GSK3B), and rs3923087 and rs11867417 (AXIN2). Unadjusted and adjusted odds ratios (OR) for the associations between family history of orofacial cleft and oral potentially malignant disorders/oral cancer, and between environmental risk factors and oral potentially malignant disorders/oral cancer were calculated using STATA software. Genotype and allele frequency comparisons between groups were conducted using PLINK Software. Statistical significance was defined as p<0.05 and 95% confidence interval (95%CI). No statistically significant association was found between family history and orofacial clefts (p = 0.52). However, place of residence (adjusted OR:5.46, p < 0.001, 95%CI: 3.76-63.543), and three genetic variants-rs1533767 (OR: 1.94, p = 0.042, 95%CI: 1.018-3.694), rs3923087 (OR: 0.58, p = 0.038, 95%CI: 0.344-0.974), rs11867417 (OR: 0.51, p = 0.010, 95%CI: 0.304-0.857)-were associated with oral potentially malignant disorders and oral squamous cell carcinoma. These findings suggest that specific environmental risk factors and genetic variants may be associated with increased susceptibility to oral potentially malignant disorders and oral cancer.

This study investigated associations between sociodemographic and professional profiles, work-related factors, and the effectiveness of oral health promotion strategies implemented by dentists in the Family Health Strategy. A cross-sectional study was conducted with 211 dentists working in Oral Health Teams within the Family Health Strategy in the state of Paraíba, Brazil. Data were collected online using a validated instrument. A matrix encompassing the core values and pillars of health promotion was employed to evaluate the effectiveness of oral health promotion strategies. Data were analyzed using Poisson regression (p < 0.05), and all analyses were performed in Stata, version 14. Greater effectiveness of oral health promotion strategies was associated with mixed Oral Health Teams (urban and rural coverage) (PR = 1.54; 95%CI: 1.154-2.076; p = 0.003) and with dentists under temporary contracts (PR = 1.67; 95%CI: 1.240-2.250; p = 0.001). The effectiveness of oral health promotion strategies was associated with work-related factors. Evaluations of oral health promotion practices are essential to support improvements in oral health management. The findings highlight the need to strengthen these practices through professionals who, in addition to having a defined employment relationship and a structured work process, value oral health promotion as a key component of care.

This study aimed to evaluate the longitudinal effect of dentition status on the perceived mobility limitation of community-dwelling Brazilian older adults. This cohort study used data from individuals who participated in the second (2006), third (2010), and fourth (2015) waves of the Health Well-being and Aging Study, conducted in the urban region of the city of São Paulo, Brazil, with adults aged 60 years and older. Mobility limitation was assessed in all waves according to reports of difficulty in performing seven activities, with higher scores representing a higher number of limitations. The independent variables of interest were number of teeth, use of dental prostheses, impact of oral health on functionality, and presence of periodontal pockets. Oral health measures were assessed by dentists, in all waves, during a clinical oral examination. The generalized linear mixed model with a Poisson distribution was used to assess longitudinal associations. All the variables were treated as time-varying in the analysis. Older adults with 20 or more teeth had a lower risk of mobility limitation than edentulous individuals, while the impact of oral health on functionality was associated with an increased risk. Similar findings were observed among dentate individuals. Periodontal disease was not associated with the outcome in dentate individuals. The associations were constant over time. The number of teeth and the impact of oral health on functionality are risk factors for mobility limitation, underscoring the importance of maintaining functional dentition for healthy aging.

Angiotensin II (Ang II) releases inflammatory mediators from several cell types. The objective of this study was to investigate the potential of Ang II to induce mRNA expression of inflammatory mediators in primary cultured fibroblast-like cells isolated from gingival and periodontal ligament tissues. A synergistic effect of co-treatment with Ang II and Interleukin-1β (IL1β) on the mRNA expression of inflammatory mediators was explored. Immunophenotyping of STRO-1, Ang II type 1 receptor (AT1R), and Ang II type 2 receptor (AT2R) was performed using flow cytometry. Cell cultures were challenged with Ang II (1 µM) for 3, 6, and 24 h with or without co-treatment with IL1β (0.1 ng/mL) for 24 h. mRNA expression of inflammatory mediators was determined using qPCR. We present, for the first time, precise quantification of AT1R and AT2R in human gingival and periodontal fibroblast-like cell types; the percentage of positive immunostaining compared to the total cell population varied from 3.35% to 5.29% for AT1R and 2.97% to 4.57% for AT2R. Ang II slightly upregulated IL6 and CCL2/MCP1 mRNA expression in gingival cells and IL8 and PTGS2/COX2 in periodontal ligament cells. IL1β upregulated IL8, IL6, CCL2/MCP1, PTGS2/COX2, and IL1β mRNA in both cell types. Co-treatment with Ang II and IL1β did not show a synergistic effect. Ang II showed a low potential to induce mRNA of inflammatory mediators, most likely owing to the low percentage of Ang II receptors in such cells and no synergistic effect with the co-treatment with IL1β.

The purpose of our review was to group the evidence and attempt to provide a consensus on the behavior of salivary flow rate in patients with Down syndrome. Observational studies evaluating salivary flow rate in children and teenagers with Down syndrome compared with non-syndrome individuals were selected. Ten sources of information were researched. The risk of bias was assessed by using the Newcastle Ottawa Scale tool . Inverse Variance was ty the SMD (95% Confidence Interval). The certainty of the evidence was determined according to the GRADE approach. Fourteen studies were evaluated. The results showed, with a very low certainty of evidence, that children and teenagers with Down syndrome present a lower salivary flow rate compared with non-syndrome controls (SMD: -1.71, 95%IC: -2.81; -0.60, p < 0.05), with significant differences in the saliva collection methods (p < 0.05) (Unstimulated saliva, SMD -5.07, 95%CI: -7.96; -2.18, p < 0.01; Stimulated saliva, SMD -0.80, 95%IC: -1.78; 0.17, p = 0.11). The behavior of the salivary flow rate is not significantly different between the age groups (p = 0.60) (up to 5 years old, SMD -1.85, 95%CI: -2.90; -0.81, p < 0.01; 2 to 18 years old, SMD -1.51, 95%CI: -2.24; -0.78, p < 0.01), and the sex (p = 0.70) (Male, SMD -1.77, 95%CI: -2.39; -1.16, p < 0.01; Female, SMD -1.53, 95%CI: -2.58; -0.48, p < 0.01). Children and teenagers with Down syndrome present a lower salivary flow rate with an unstimulated saliva collection method compared to non-syndrome.

Tumor necrosis factor-alpha (TNF-α) is a cytokine involved in the immune-inflammatory response. It can induce an odontoblastic phenotype and enhance biomineralization in dental pulp mesenchymal stem cells but does not have the same effect on osteoblasts. The reasons for this differential response, despite the shared lineage of these cell types, are not yet clear. This study examined the effects of TNF-α on immortalized mouse dental pulp stem cells (OD-21) and pre-osteoblastic cells (MC3T3-E1). Cells were treated with recombinant TNF-α at concentrations of 1, 10, and 100 ng/mL. Cell viability, proliferation, and migration were assessed using the MTT, CyQUANT, and wound healing assays, respectively. Gene expression was assessed via real-time RT-PCR, and biomineralization was evaluated using alizarin red staining. Statistical analysis was conducted using one-way ANOVA followed by Tukey's post-hoc test (α = 0.05). TNF-α did not affect cell viability at any concentration (p > 0.05). Proliferation and migration increased after 12 h, with near-complete wound closure by 24 h. TNF-α promoted proliferation and migration in both cell types. OD-21 cells exhibited high levels of Tnfr1 and Runx2 expression and showed biomineralization. In contrast, MC3T3-E1 cells showed high Tnfr2 levels, suppressed Runx2, and inhibited biomineralization. These results highlight how TNF-α influences different cell types from the same lineage in distinct ways.

The aim of this in-vitro study was to verify which field of view (FOV) in cone-beam computed tomography (CBCT) yields greater accuracy in the detection of internal root resorption (IRR) volume, in comparison to the gold standard of micro-computed tomography (micro-CT) and to a physical method. Twenty-five extractedsingle-rooted teeth were scanned by CBCT with two different FOV parameters (6x6-FOV and 10x10-FOV) and via micro-CT. The volume of dental hard tissue was measured on these images. A simulated IRR was produced by a demineralization protocol. After the simulated IRR, the volumes of the dental hard tissue and the simulated IRR were measured with the same scanning parameters. In addition, the volume of the simulated IRR was measured via a physical method. The simulated IRR volumes obtained by CBCT, micro-CT, and the physical method were statistically compared using one-way ANOVA. Before the simulated IRR, the mean volume of dental hard tissue obtained by 6x6-FOV, 10x10-FOV, and micro-CT were 266.64 ± 11.56, 284.78 ± 14.99, and 233.07 ± 19.91, respectively. The simulated IRR mean volumes obtained by 6x6-FOV, 10x10-FOV, micro-CT, and the physical method were 19.35 ± 5.92, 17.43 ± 5.20, 23.85 ± 6.63, and 13.51 ± 3.11, respectively. The mean volume of the simulated IRR obtained by micro-CT was similar to that of the 6x6-FOV and was significantly different from that of the 10x10-FOV and physical method. The mean volume value of simulated IRR obtained by the physical method was significantly different from those of the micro-CT and 6x6-FOV groups. In conclusion, the 6x6-FOV was better than the 10x10-FOV for the detection of IRR volume by CBCT under clinical conditions.

The aim of the study was to explore female authorship in various aspects of randomized controlled trials (RCTs) in dentistry. A search was performed in PubMed for RCTs, in dentistry, indexed from 12/31/2016 to 12/31/2021. Only studies in English were considered. Data selection and extraction were performed by two authors and the following data collected: year of publication, journal, subject, number and names of authors, and country and gender (Genderize website) of the first 10 authors. Descriptive analyses, graphs, and maps were generated. Poisson regression assessed the influence of continent and year of publication on the presence of women as first or last authors. The results were presented as prevalence ratios (PR) and 95% confidence intervals (95%CI). A total of 844 RCTs and 4,305 authors (2,372 men and 1,662 women) were included. Gender disparity increases as the order of authorship advances. Among first authors, men represent 50.59% and women 44.08%, whereas among last authors, they account for 61.92% and 34.03%, respectively. Analyses showed no association between year of publication and the presence of women as authors. There were fewer women as first authors in Europe (PR: 0.82, 95%CI: 0.68-0.99) and as last authors in Europe and Asia (PR: 0.68, 95%CI: 0.53-0.87 and PR: 0.79, 95%CI: 0.63-0.99, respectively). The findings highlight a lower presence of female authors in all aspects analyzed in the RCTs, especially in last authorship. Also, there has been no indication of improvement in recent years. Female participation in RCTs is crucial not only for gender equity but also as a means to enhance the quality and relevance of clinical data for decision-making.